The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: A prospective, single-arm, single-center, phase II clinical study.
 
Xi Chen
No Relationships to Disclose
 
Shuqun Zhang
No Relationships to Disclose
 
Xuexin Li
No Relationships to Disclose
 
Yinbin Zhang
No Relationships to Disclose
 
Youhuai Li
No Relationships to Disclose
 
Huafeng Kang
No Relationships to Disclose
 
Guan Haitao
No Relationships to Disclose
 
Qing She
No Relationships to Disclose
 
Xiaobin Ma
No Relationships to Disclose
 
Yan Diao
No Relationships to Disclose
 
Di Liu
No Relationships to Disclose
 
Weili Min
No Relationships to Disclose
 
Mengjie Liu
No Relationships to Disclose
 
Fei Wu
No Relationships to Disclose
 
Cong Feng
No Relationships to Disclose